Jinxian He

1.2k total citations · 1 hit paper
26 papers, 806 citations indexed

About

Jinxian He is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Jinxian He has authored 26 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Jinxian He's work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Jinxian He is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Jinxian He collaborates with scholars based in China, United States and Italy. Jinxian He's co-authors include Weiliang Wu, Weiyu Shen, Xiaodan Meng, Hui Tian, Shuai Fang, Jinchang Pan, Zhaohui Gong, Chengwei Zhou, Xin Jin and Haihua Tian and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Medicine.

In The Last Decade

Jinxian He

25 papers receiving 801 citations

Hit Papers

Incidence and mortality trend of congenital heart disease... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017
    2020 226 citations Jinxian He et al. profile →

Peers

Jinxian He
Eddie Chan Hong Kong
Mark Rochester United Kingdom
Jie Cai China
Kenji Nishii Japan
Avital Avriel Israel
Mitsuhiro Sunohara Japan
Derry Minyao Ng China
Domenico Loizzi Italy
I Popov Serbia
Eddie Chan Hong Kong
Jinxian He
Citations per year, relative to Jinxian He Jinxian He (= 1×) peers Eddie Chan

Countries citing papers authored by Jinxian He

Since Specialization
Citations

This map shows the geographic impact of Jinxian He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxian He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxian He more than expected).

Fields of papers citing papers by Jinxian He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxian He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxian He. The network helps show where Jinxian He may publish in the future.

Co-authorship network of co-authors of Jinxian He

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxian He. A scholar is included among the top collaborators of Jinxian He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxian He. Jinxian He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jian, Lin Yang, Jianhao Li, et al.. (2025). MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy. Stem Cell Research & Therapy. 16(1). 40–40. 5 indexed citations
2.
3.
He, Jinxian, et al.. (2024). circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR‐155‐5p/FZD5 axis. Journal of Biochemical and Molecular Toxicology. 38(6). e23742–e23742. 4 indexed citations
4.
5.
He, Jinxian, Gaofeng Liang, Weiyu Shen, et al.. (2024). Two versus three to four cycles of neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice. Journal of Thoracic Disease. 16(10). 6999–7015. 2 indexed citations
6.
Ma, Xinyi, Zhenhua Chen, Wei Chen, et al.. (2024). LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 20–20. 13 indexed citations
7.
Wang, Lijie, Jinxian He, Liang Zhang, et al.. (2024). Use of a novel claw-suture technique for localization of solitary pulmonary nodules: retrospective study and experience from one center. Journal of Thoracic Disease. 16(12). 8699–8708. 1 indexed citations
8.
He, Jinxian, et al.. (2024). Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases. Frontiers in Oncology. 13. 1338809–1338809. 5 indexed citations
9.
Chen, Zhenhua, Xinyi Ma, Ziyuan Chen, et al.. (2024). Exosome-transported circ_0061407 and circ_0008103 play a tumour-repressive role and show diagnostic value in non-small-cell lung cancer. Journal of Translational Medicine. 22(1). 427–427. 14 indexed citations
10.
He, Jinxian, Gaofeng Liang, Hui Tian, et al.. (2023). Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma. Frontiers in Oncology. 12. 1014902–1014902. 9 indexed citations
11.
Wang, Lijie, Jinxian He, Liang Zhang, et al.. (2023). A novel preoperative image-guided localization for small pulmonary nodule resection using a claw-suture device. Scientific Reports. 13(1). 18950–18950. 3 indexed citations
12.
Chen, Tian, et al.. (2022). Prognostic value of prognostic nutritional index and its variations in advanced non‐small‐cell lung cancer patients treated with anlotinib monotherapy. Journal of Clinical Laboratory Analysis. 36(4). e24300–e24300. 7 indexed citations
13.
14.
15.
Pan, Jinchang, Shuai Fang, Haihua Tian, et al.. (2020). lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Molecular Cancer. 19(1). 9–9. 240 indexed citations
16.
Pan, Jinchang, Chengwei Zhou, Xiaodong Zhao, et al.. (2018). A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer. Scientific Reports. 8(1). 16699–16699. 85 indexed citations
17.
Jiang, Nan, Xiaodan Meng, Shenghui Li, et al.. (2018). Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer. Clinica Chimica Acta. 486. 26–33. 87 indexed citations
18.
Liu, Kai, et al.. (2013). Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. Tumor Biology. 35(3). 2063–2068. 5 indexed citations
19.
20.
Jiang, Lijun, et al.. (2011). The Hemodynamic Effect of Total Liquid Ventilation in Piglets With Reduced Cardiac Function After Cardiopulmonary Bypass. Artificial Organs. 35(7). 737–741. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eddie Chan Breakdown of academic impact, for papers by Mark Rochester Breakdown of academic impact, for papers by Jie Cai Breakdown of academic impact, for papers by Kenji Nishii Breakdown of academic impact, for papers by Avital Avriel Breakdown of academic impact, for papers by Mitsuhiro Sunohara Breakdown of academic impact, for papers by Derry Minyao Ng Breakdown of academic impact, for papers by Domenico Loizzi Breakdown of academic impact, for papers by I Popov
Rankless by CCL
2026